Project Grant 2222602
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a novel platform for accelerating the strain development process for precision fermentation. The $275,000 grant, awarded on January 15, 2025, will fund the recipient, Terraferma Foods, Inc., to leverage machine learning and experimental biology to enhance the industrial-scale production of animal proteins in yeast. The project...
- New Horizon Biotech Inc. received a $256,000 National Science Foundation SBIR Phase I Project Grant to determine performance characteristics during cultivation of living organisms in a novel single-use horizontal modular and pressurizable microbial fermentor. The funding period is from February 15, 2021 through May 31, 2023 under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). This program seeks to advance science, engineering, and technology innovations to address...
- This Project Grant award from the National Science Foundation (NSF) under its Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Tectaria Bio LLC to engineer cell lines with activated proteasomes for increased biomanufacturing efficiency. The project aims to test the feasibility and application of a novel technology to significantly increase the protein production capabilities of cell lines used in the manufacture of biologics, gene therapies, and vaccines....
- This $256,000 Project Grant was awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program. The award to Terragia Biofuel Inc., a for-profit organization, aims to develop innovative bioprocessing technologies for converting lignocellulosic biomass into hydrocarbon fuels and products. Specifically, the project is focused on demonstrating the feasibility of a technique called Continuous Evolution with Multiplex Natural Transformation...
- This $500,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), will support research to develop an end-to-end continuous manufacturing process for cell therapies using robotics and microfluidic technologies. The Georgia Tech Research Corporation will receive funding to create a more integrated workflow based on microfluidic device-enabled genetic engineering, cell expansion, and...
- Via Biofuels Inc. received a $175,000 Project Grant from the Institute of Bioenergy, Climate, and Environment under the Small Business Innovation Research (SBIR) Program (CFDA 10.212) effective September 1, 2025, with a completion date of April 30, 2026. The award supports development of a genetically engineered yeast strain capable of converting lactose from whey permeate—a dairy industry waste product—into 3-methylanisole (3-MA), a versatile molecule suitable as a gasoline replacement and...
- The National Science Foundation awarded Opera Bioscience, Inc. $275,000 under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a low-cost bacterial production platform for manufacturing high purity recombinant proteins and growth factors. The award period runs from June 15, 2023 through May 31, 2024. Opera Bioscience will utilize this funding to demonstrate the ability of its innovative protein production platform to solve challenges in traditionally costly and...
- The National Science Foundation (NSF) awarded a $274,980 SBIR Phase I Project Grant to Cisterna Biologics, Inc. to develop a novel platform for cost-efficient mRNA production in yeast. The project aims to transform yeast cells into efficient mRNA factories and utilize advanced chromatographic techniques for purification, with the goal of reducing mRNA manufacturing costs by 90% compared to current in vitro transcription methods. Key technical objectives include demonstrating stable mRNA fusion...
- This SBIR Phase I award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $273,111 to Hoofprint Biome, Inc. to develop a probiotic yeast technology that can reduce methane emissions from cattle by at least 30%, and potentially up to 98%. The technology involves screening and optimizing enzymes that restrict methane production in the cattle rumen, and then packaging these enzymes for delivery via a probiotic yeast. The...
- This SBIR Phase I award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Caravel Bio, Inc. to develop a novel synthetic biology platform for high-throughput directed evolution of spore-displayed enzymes. The project aims to create customizable enzyme solutions for industrial biocatalyst applications by improving key properties like enzyme activity, stability, and loading density. The technology uses a...
SBIR PHASE I: BOOSTING INDUSTRIAL BIO-FERMENTATION WITH MICROBIAL STEM CELLS -THE BROADER IMPACT OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT IS TO REIMAGINE BIO-MANUFACTURING WITH A NOVEL PLATFORM TECHNOLOGY THAT COULD BOOST THE YIELDS OF MANY PRODUCTS, INCLUDING FOOD ADDITIVES, BIOMATERIALS PRECURSORS, BIOFUELS, AND PHARMACEUTICALS. THE TECHNOLOGICAL ADVANCEMENT ADDRESSES A FUNDAMENTAL ISSUE THAT LIMITS CONVENTIONAL BIO-FERMENTATION, WHICH IS THAT PRODUCING CELLS SUFFER LIMITED HEALTH AND VIABILITY IN EXCHANGE FOR HIGHER YIELDS. IN THIS PROPOSAL, GENETIC TOOLS WILL BE USED TO DIVIDE THE LABOR OF CELL REPRODUCTION AND PRODUCT SYNTHESIS INTO TWO DIFFERENT CELL TYPES, CALLED STEM CELLS AND FACTORY CELLS. AS OLDER FACTORY CELLS BECOME EXHAUSTED, PRODUCTIVITY IS MAINTAINED BY NEW FACTORY CELLS, WHICH ARE BORN FROM THE STEM CELL POPULATION. THE APPROACH MAY BE PARTICULARLY WELL SUITED TO BIOFUELS AND OTHER MOLECULES THAT ARE DIFFICULT TO PRODUCE IN LARGE QUANTITIES BY CONVENTIONAL BIO-FERMENTATION BECAUSE THE PRODUCT IS TOXIC TO THE CELLS THAT MAKE IT. IT COULD BE APPLIED TOWARD INCREASING THE PROFITABILITY OF EXISTING BIO-PROCESSES AND ALSO FOR BRINGING NEW PRODUCTS TO MARKET, WHICH ARE CURRENTLY TOO DIFFICULT TO PRODUCE. IN THIS PROJECT, THE TEAM SEEKS TO DEMONSTRATE THE BENEFITS OF PRODUCING A FUEL (LIMONENE) AND A DAIRY ENZYME (CHYMOSIN), AS PROOF OF ITS APPLICATION IN BIOFUEL AND AGRICULTURAL SECTORS. BROAD INDUSTRIAL IMPLEMENTATION WILL ADVANCE BIO-MANUFACTURING TOWARD THE ?GREEN? REVOLUTION, CONTRIBUTING TO THE DEVELOPMENT OF CLEANER INDUSTRIES AND DECREASING US AND GLOBAL RELIANCE ON FOSSIL FUELS. THIS PROJECT AIMS TO SOLVE TWO MAJOR LIMITATIONS OF MICROBIAL FERMENTATION PROCESSES: METABOLIC EXHAUSTION AND GENETIC DRIFT. THESE ARE NEARLY UNIVERSAL PROBLEMS IN THE INDUSTRY. HIGHLY PRODUCING CELLS CAN BECOME INACTIVE DUE TO THE LACK OF METABOLIC RESOURCES, CYTOTOXIC EFFECTS OF PRODUCTS, AND MUTATIONS THAT BREAK THE BIOSYNTHETIC PATHWAY. IN THIS PROJECT, MICROBIAL STEM CELL TECHNOLOGY (MIST) UNCOUPLES GROWTH AND PRODUCTION BY ESTABLISHING A MULTICELLULAR SYSTEM. ONE CELL TYPE IS DEDICATED TO PRODUCT SYNTHESIS (FACTORY CELLS), WHILE ANOTHER (STEM CELLS) IS RESPONSIBLE FOR CELL DIVISION AND THE GENERATION OF NEW FACTORY CELLS. AS OLDER FACTORY CELLS LOSE PRODUCTIVITY, THE BIOREACTOR IS CONTINUOUSLY REPLENISHED WITH NEW FACTORY CELLS, DERIVED FROM THE STEM CELL POPULATION. BY MAINTAINING AN ACTIVE FACTORY CELL POPULATION, MIST-SUPPORTED CULTURES ARE EXPECTED TO EXHIBIT INCREASED PRODUCTION LONGEVITY AND HIGHER OVERALL YIELD THAN CONVENTIONAL BIO-FERMENTATIONS. THIS PROJECT AIMS TO VALIDATE THE TECHNOLOGY IN E. COLI ENGINEERED TO PRODUCE LIMONENE, A PRECURSOR FOR BIODIESEL AND OTHER USEFUL CHEMICALS. IN THE FACTORY CELLS, T7RNAP WILL DRIVE HIGH-LEVEL EXPRESSION OF A SUITE OF BIOSYNTHETIC ENZYMES. SINCE LIMONENE HAS A CYTOTOXIC EFFECT ON PRODUCING CELLS, MIST-SUPPORTED FACTORY CELL REPLENISHMENT IS EXPECTED TO INCREASE PRODUCTIVITY BY MORE THAN 2-FOLD COMPARED TO THE CONVENTIONAL LIMONENE-PRODUCING STRAINS. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/30/24 | ||
| Not listed | $0 | 8/16/24 | ||
| Not listed | $274.1k | 4/27/23 |